Annual Meeting approaches at the end of this month, Merck & Co joined a host of other companies that have announced upcoming ...

Swiss cancer giant Novartis (NOVN: VX) and German drugmaker Bayer (BAYN: DE) are among the latest companies to lift the lid on upcoming data presentations at ASCO 2024.

In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Cullinan Management (CGEM – Research Report), with a ...

MAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual ...

ASCO has informed the Company that the previously accepted MDNA11 oral abstract has been withdrawn due to alleged violation ...

Arcus Biosciences is preparing for a readout at the ASCO Annual Meeting, which could be a significant catalyst. See why I ...

NTX-472 is a tri-specific, mRNA-encoded medicine targeting CD20, CD19, and CD47 for the treatment of B cell lymphoma.

Incyte (Nasdaq: INCY) today announced that several abstracts featuring data from its oncology portfolio will be presented at ...

The“Jabbar Hashimov” oil products tanker belonging to the fleetof Azerbaijan Caspian Shipping Company (ASCO) has been ...

Japanese pharma major Takeda (TYO: 4502) will present results across a range of cancers, including colorectal, lung, ...